Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Shinsuke Harasawa"'
Autor:
Shinichiro Niizuma, Yoshitaka Iwanaga, Takehiko Washio, Tadashi Ashida, Shinsuke Harasawa, Shunichi Miyazaki, Naoya Matsumoto
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-13 (2019)
Background: An increased cardiac troponin T (cTnT) level identifies a high-risk group in patients with end-stage renal disease; however, the mechanism of cTnT elevation remains unclear in such patients without acute coronary syndrome (ACS). Therefore
Externí odkaz:
https://doaj.org/article/422ad534d56b41c5a21605fb09d76749
Autor:
Tadashi Ashida, Shunichi Miyazaki, Naoya Matsumoto, Shinsuke Harasawa, Yoshitaka Iwanaga, Shinichiro Niizuma, Takehiko Washio
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-13 (2019)
Background: An increased cardiac troponin T (cTnT) level identifies a high-risk group in patients with end-stage renal disease; however, the mechanism of cTnT elevation remains unclear in such patients without acute coronary syndrome (ACS). Therefore
Publikováno v:
Iranian Journal of Radiology. 17
Background: Vascular calcification, including medial and intimal calcification leading to luminal stenosis of the lower extremities are commonly associated with hemodialysis (HD), whereas their distribution has not been assessed comprehensively. Thre
Publikováno v:
Iranian Journal of Radiology; Jan2020, Vol. 17 Issue 1, p1-5, 5p
Autor:
Miho Saitou, Keiichi Akiyama, Atsushi Hirayama, Ken Nagao, Michiaki Matsumoto, Takehiko Washio, Hirofumi Kawamata, Shinsuke Harasawa, Katsuaki Okubo, Narimichi Kumabe, Toshio Kushiro, Tatsumasa Tani, Hiroshi Yamada, Takaaki Miki
Publikováno v:
Journal of Nihon University Medical Association. 72:225-231
Autor:
Ken Nagao, Shinsuke Harasawa, Katsuaki Okubo, Yuji Otsuka, Atsushi Hirayama, Miyuki Koike, Toshio Kushiro, Hirotaka Fujita
Publikováno v:
Journal of Pharmacy and Pharmacology. 62:1740-1745
Objectives Amlodipine, a calcium channel blocker (CCB), is one of the most common antihypertensive medicines in Japan. We evaluated whether the calcium channel blocker confers cardiac protection through the renin–angiotensin–aldosterone system in
Autor:
Kiyoshi Iida, Takehiko Washio, Daisuke Kiso, Hirofumi Kawamata, Naoya Matsumoto, Tadashi Ashida, Masakazu Matsuzaki, Atsushi Hirayama, Katsuaki Ookubo, Shinsuke Harasawa
Publikováno v:
Journal of Cardiac Failure. 20:S192-S193
Autor:
Toshiyuki Horie, Yukari Date, Yoshinobu Hoshii, Noriko Kinukawa, Shinsuke Harasawa, Haruhiko Akiyama, Takayoshi Watanabe, Hiroshi Yagi, Katsuo Kanmatsuse, Fumio Saito, Ryouhei Hisaki, Yasuyuki Kitahara, Chikao Yutani, Tatsuo Sakamaki, Yoshikazu Iwasaki, Masamitsu Nakazato
Publikováno v:
Human Pathology. 32:237-239
A new transthyretin (TTR) variant (lysine 92), which causes late onset cardiac amyloidosis, is described in a 71-year-old man. The patient at first had syncope due to ventricular tachycardia and was admitted our hospital. Typical findings of cardiac
Autor:
Takashi Uchiyama, Kouji Oiwa, Fumio Saito, Katsuo Kanmatsuse, Naoyuki Takahashi, Atsuhiko Takahashi, Shinsuke Harasawa, Toshio Kushiro, Yuji Otsuka, Hirotaka Fujita, Izumi Ichiyama
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 30(1)
In hypertensive patients with chronic renal disease, angiotensin receptor blockers (ARBs) are among the first-line drugs, and calcium channel blockers (CCBs) are recommended as a second line. We examined the effects of two therapeutic strategies usin